A biomarker-validated time scale in years of disease progression has identified early- and late-onset subgroups in sporadic Alzheimer’s disease

A biomarker-validated time scale in years of disease progression has identified early- and late-onset subgroups in sporadic Alzheimer’s disease

Abstract Background It is possible to calculate the number of years to the expected clinical onset (YECO) of autosomal-dominant Alzheimer’s disease (adAD). A similar time scale is lacking for sporadic Alzheimer’s disease (sAD). The purpose was to design and validate a time scale in YECO for patients...

Full description

Bibliographic Details
Main Authors: Ove Almkvist, Agneta Nordberg
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Alzheimer’s Research & Therapy
Subjects:
Alzheimer’s disease
Time scale
Progression
Disease onset
Cognition
EOAD
Online Access:https://doi.org/10.1186/s13195-023-01231-8

Internet

https://doi.org/10.1186/s13195-023-01231-8

Similar Items